The Association of Obstetricians and Gynecologists of South Sudan (AGOSS) is profoundly grateful to EVA Pharma, our esteemed partner, for their consistent and invaluable support. On behalf of our members and the entire medical community we represent, we extend our heartfelt appreciation to EVA Pharma for standing with us in our mission to improve maternal, reproductive, and child health across South Sudan.
Partnerships form the backbone of any meaningful transformation in healthcare. For AGOSS, a professional body dedicated to advancing the highest standards of obstetric and gynecological care in South Sudan, partnerships such as the one we have with EVA Pharma are not simply transactional collaborations. They are long-term commitments to shared values, shared missions, and shared responsibility for improving the well-being of women, mothers, newborns, and families in our nation.
EVA Pharma’s support to AGOSS has been nothing short of transformative. It has allowed us to strengthen our capacity as a professional association, to implement initiatives that would otherwise remain dreams, and to provide platforms for knowledge exchange among healthcare practitioners. In a country like South Sudan, where the healthcare system faces unique challenges, the contribution of partners like EVA Pharma is a lifeline. Their presence is a demonstration of solidarity, a message that South Sudan is not alone in the journey to improve healthcare, and a reminder that collective efforts always yield stronger results.
Why EVA Pharma’s Support Matters
The healthcare needs of South Sudan are complex and pressing. Maternal mortality rates remain among the highest in the world, access to quality reproductive healthcare is uneven, and many communities continue to grapple with barriers to healthcare such as distance, cost, and inadequate infrastructure. Against this backdrop, AGOSS works tirelessly to train, mentor, and support healthcare professionals while also advocating for policies that place women and children at the heart of national development.
However, the scope of our mission cannot be achieved in isolation. It requires partners who understand the importance of investing in health, partners who believe in the value of science and evidence, and partners who are willing to commit resources to support professional organizations. EVA Pharma has demonstrated these qualities time and again. Their contributions are not merely financial; they represent a genuine belief in the vision of AGOSS and in the future of healthcare in South Sudan.
EVA Pharma’s involvement has supported capacity-building programs, scientific conferences, workshops, and professional networking events. These platforms have given South Sudanese doctors opportunities to learn, share experiences, and strengthen their ability to respond to the health needs of mothers and children. In this sense, EVA Pharma has not only supported AGOSS as an institution but has also directly invested in the professional growth of individual practitioners, the future leaders of healthcare in South Sudan.
A Partnership Rooted in Shared Values
What makes the partnership between AGOSS and EVA Pharma particularly meaningful is the alignment of values. Both organizations are deeply committed to advancing healthcare through innovation, evidence, and collaboration. EVA Pharma’s philosophy of providing accessible, high-quality medicines and solutions resonates with AGOSS’s mission of ensuring that every woman, mother, and child in South Sudan has the opportunity to enjoy good health and well-being.
Through this partnership, we see more than an exchange of resources; we see a meeting of visions. EVA Pharma understands that investing in healthcare professionals ultimately leads to better care for patients. They understand that empowering associations like AGOSS creates ripple effects across the healthcare system. And they understand that true corporate responsibility goes beyond markets—it extends to building healthier societies.
The Impact of EVA Pharma’s Support
AGOSS has witnessed tangible changes as a result of EVA Pharma’s partnership. Our scientific conferences have become stronger, more impactful, and more inclusive. These conferences, which bring together obstetricians, gynecologists, pediatricians, and other healthcare professionals, are vital platforms for learning and innovation. EVA Pharma’s backing has made it possible to host such events, creating spaces for dialogue on critical issues such as maternal mortality reduction, family planning, reproductive rights, and the integration of modern technologies into healthcare.
Moreover, EVA Pharma’s support has allowed AGOSS to broaden its outreach. With their partnership, we have been able to advocate more effectively for women’s health, reach policymakers with evidence-based recommendations, and expand training opportunities for young doctors and medical students. In this way, the partnership contributes not only to today’s progress but also to the long-term strengthening of the medical profession in South Sudan.
A Symbol of Hope and Possibility
In South Sudan, where healthcare challenges are often overwhelming, partnerships like the one between AGOSS and EVA Pharma serve as symbols of hope. They remind us that even in the most difficult circumstances, progress is possible when institutions and partners work together. They remind our members that their work is recognized, valued, and supported—not only within our borders but also by organizations that share our global vision for healthier futures.
AGOSS members often speak of the encouragement they feel knowing that EVA Pharma stands beside them. It is more than support—it is a statement of confidence in South Sudanese healthcare professionals. It is an affirmation that, despite the challenges we face, our efforts are making a difference, and we are not alone.
Looking Ahead: Strengthening the Partnership
As we look to the future, AGOSS envisions an even stronger relationship with EVA Pharma. We see opportunities for deeper collaboration in areas such as training programs for healthcare workers, public health education campaigns, and joint initiatives aimed at reducing maternal and child mortality. We also see opportunities to expand our scientific exchange and bring more South Sudanese professionals into regional and international conversations about reproductive health.
Together with EVA Pharma, we aspire to build a stronger healthcare system where evidence-based practice guides policy, where doctors are empowered to lead with knowledge, and where patients—particularly women and children—receive the care they deserve. We are confident that this partnership will continue to flourish and produce even greater impact in the years ahead.
Conclusion
On behalf of the Association of Obstetricians and Gynecologists of South Sudan, we once again express our deepest appreciation to EVA Pharma. Your partnership means more than words can fully capture. You have given us the tools to build capacity, the resources to create platforms for dialogue, and the encouragement to continue striving for excellence despite challenges.
We thank you not only for what you have done but also for what you continue to do—for standing with us, for believing in us, and for investing in the health and future of South Sudan. Together, AGOSS and EVA Pharma are writing a story of resilience, collaboration, and transformation, one that will be remembered as a defining chapter in the journey toward a healthier nation.
From every member of AGOSS, and on behalf of every mother, newborn, and family whose lives are touched by our collective efforts, we say with sincerity: EVA Pharma, we appreciate you so much. Thank you for being our trusted partner.